As evidence generation becomes more advanced and integrated into Medical Affairs strategic plans, there is a greater need to maximize its impact by leveraging emerging digital technologies to communicate complex clinical and nonclinical data.
In this episode, listeners will better understand what innovative content is in the context of Medical Information while setting expectations of HCPs in accessing innovative content.
In late January, MAPS published an article by Rahul Mandlik describing the use of ChatGPT in Medical Affairs. The result was a LinkedIn Discussion with over 40,000 views in its first 6 days. During this webinar, thought leaders in this space vision how ChatGPT may augment or, at times, undermine the practice of Medical Affairs in areas such as Medical Information, Omnichannel engagement and more. This is your chance to engage in the discussion of this absolutely cutting-edge topic. Is ChatGPT just another techno-fad? Will it fundamentally transform the Medical Affairs? What are the opportunities and dangers of this new technology? Bring your questions and join us for this interactive session.
This article provides top-level framework and broad conceptual categories for understanding digital structures within Medical Affairs and biopharmaceutical/MedTech organizations, helping leaders to make organizational decisions to drive their digital strategy with intention and purpose.
In this our third episode this season, we’ll be discussing how and why medical publishing is changing and where is it going in the future.
With a multibillion dollar investment from Microsoft and already 4 authorship credits on PubMed, ChatGPT is poised to disrupt Medical Affairs.
The webinar discusses how to engage with Digital Opinion Leaders (DOLs) and how they can be a valuable source of insights, with a strong focus on the compliance aspects. Increasing numbers of pharma stakeholders are active in social media and thereby present an open and accessible opportunity for the gathering of insights. When Pharma listens to these DOLs it needs to be done in a compliant way. The same applies to the engagement with DOLs. The webinar addresses these topics and the important role Medical has to play when listening and engaging with DOLs.
In this our second episode this season, we’ll be discussing open access in medical publishing from the biopharma perspective.
In episode 1 of this 4-part series, a panel of experts focus on the struggles and successes of compliance in Medical Communications.
In this webinar, experts will:
1.    Discuss the current environmental landscape for conversational AI/Chatbots
2.    Provide practical learning through a case study presentation on how to implement conversational AI/Chatbots (KPIs, use cases, metrics, learnings)
3.    Identify and debate legal and regulatory considerations when implementing conversational AI/Chatbots